New drug NT-88 aims to improve heart function in 60 patients
NCT ID NCT07509801
First seen Apr 24, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This study tests a new drug called NT-88 in 60 adults with chronic heart failure where the heart's pumping ability is mildly reduced. The goal is to see if NT-88 is safe and can improve heart function, symptoms like shortness of breath, and fatigue. Participants will be monitored for side effects and changes in heart function over the trial period.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.